CLINICAL_TRIALS
trial_result
· 2022-02-08
Clinical Trial Update: Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis [Phase 2]
Summary
Phase 2 open-label study assessing safety and efficacy of a topical investigational drug for psoriasis; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-02-08